Zymeworks Inc.

About Zymeworks Inc.

Zymeworks is dedicated to making a meaningful difference by developing novel medicines for patients with difficult-to-treat diseases. They focus on transforming areas of high unmet medical need through revolutionary technologies and a fully integrated R&D engine, aiming to deliver transformational therapies for cancers and other serious diseases.

Products & Services

Multifunctional Therapeutics:A growing pipeline of novel therapeutics supported by best-in-class antibody-drug conjugates and multispecific antibody therapeutics technology platforms.

Specialties

Antibody-Drug Conjugates Multispecific Antibody Therapeutics Biotherapeutics Engineering Cancer and Serious Disease Treatments in-house R&D proprietary platforms antibody science global partnerships

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Royalty-backed note T: - FT: Royalty-backed note	A: 250000000 MR: - FA: $250 million FAN: 250000000	D: 2026-03-02 FD: 2026-03-02	1 investors
2	RT: Royalty-backed note financing T: - FT: Royalty-backed note financing	A: 250000000 MR: - FA: $250 million FAN: 250000000	D: 2026-03-02 FD: 2026-03-02	1 investors
3	RT: Private Placement T: - FT: Private Placement	A: 50000000 MR: - FA: $50 million FAN: 50000000	D: 2023-12-26 FD: 2023-12-26	1 investors

Royalty-backed note Latest

2026-03-02

$250.0M

1 investor (Pro only)

Royalty-backed note financing 2026-03-02

$250.0M

Private Placement 2023-12-26

$50.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

K

Kenneth Galbraith

Chair & CEO

K

Kristin Stafford

Chief Financial Officer

S

Sabeen Mekan

Senior Vice President and Chief Medical Officer

P

Paul Moore

Chief Scientific Officer

M

Mark Hollywood

Executive Vice President and Chief Operating Officer

S

Scott Platshon

Executive Vice President and Chief Business Officer

View 21 more team members with Pro

Unlock Full Team Directory

Recent News

Zymeworks Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised